Literature DB >> 32975472

Intracortical motor conduction is associated with hand dexterity in progressive multiple sclerosis.

Marco Pisa1, Raffaella Chieffo2, Martina Congiu3, Gloria Dalla Costa4, Federica Esposito5, Marzia Romeo5, Mauro Comola5, Giancarlo Comi1, Letizia Leocani1.   

Abstract

BACKGROUND: Hand dexterity dysfunction is a key feature of disability in people with progressive multiple sclerosis (PMS). It underlies corticospinal tract (CST) and cerebellar integrity, as well as disruption of cortical networks, which are hardly assessed by standard techniques. Transcranial magnetic stimulation is a promising tool for evaluating the integrity of intracortical motor pathways.
OBJECTIVE: To investigate neurophysiological correlates of motor hand impairment in PMS.
METHODS: Antero-posterior (AP) stimulation of the primary motor cortex activates the CST indirectly through polysynaptic pathways, while a direct CST activation occurs with latero-medial (LM) directed current. Thirty PMS and 15 healthy controls underwent dominant hand motor evoked potentials (MEP) using AP and LM-directed stimulation, and a clinical assessment of dexterity (nine-hole peg test) and strength (MRC scale, grip and pinch).
RESULTS: PMS with AP-LM latency difference 2.5 standard deviation above the mean of controls (33%) showed worse dexterity but no difference in upper limb strength. Accordingly, AP-LM latency shortening predicted dexterity (R2 = 0.538, p < 0.001), but not strength impairment. On the contrary, absolute MEP latencies only correlated with strength (grip: R2 = 0.381, p = 0.014; MRC: R2 = 0.184, p = 0.041).
CONCLUSION: AP-LM latency shortening may be used to assess the integrity polysynaptic intracortical networks implicated in dexterity impairment.

Entities:  

Keywords:  Multiple sclerosis; TMS; cortical plasticity; dexterity; motor evoked potentials

Year:  2020        PMID: 32975472     DOI: 10.1177/1352458520960374

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  1 in total

Review 1.  Novel Drugs in a Pipeline for Progressive Multiple Sclerosis.

Authors:  Klaudia Sapko; Anna Jamroz-Wiśniewska; Konrad Rejdak
Journal:  J Clin Med       Date:  2022-06-10       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.